Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel toluene-based Kolbe-Schmitt process yields >99.5% purity antioxidant intermediate with superior safety and cost efficiency for industrial scale-up.
Novel UIO-66 solid acid catalyst method for high-purity R-2-chloropropionic acid. Reduces waste and improves supply chain reliability for pharmaceutical intermediates.
Novel diazotization route avoids toxic cyanide. Scalable cosmetic intermediate manufacturing with high purity and reduced environmental impact.
Patent CN107840828B reveals a high-yield one-step fluorination route for 2-chloro-5-trifluoromethylpyrazine, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis route for herbicide intermediate Flumioxazin precursor offering cost reduction and supply chain reliability for agrochemical manufacturing partners.
Patent CN101948389A reveals a high-yield route for Flumioxazin intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for this critical agrochemical building block.
Novel Pd-NHC catalyzed process offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability for global partners.
Advanced indirect electrooxidation patent CN104805466B offers sustainable manufacturing for high-purity pharmaceutical intermediates with reduced waste.
Patent CN1023117C details a novel oxidation route for 2,2'-biphenyldicarboxylic acid using ruthenium tetroxide and sodium hypochlorite, offering significant cost and purity advantages.
Patent CN102010279A details a rapid, green method for aryl ethylene derivatives using PEG-400 and PdCl2, offering significant cost and time advantages for pharmaceutical intermediate manufacturing.
Patent CN102875455A reveals a scalable Hofmann degradation route for 3,6-dichloro-2-aminopyridine, eliminating cryogenic lithiation and reducing manufacturing costs significantly.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN114605458A details a novel Rh-catalyzed C-C bond activation method for high-purity chiral intermediates, offering significant cost reduction in API manufacturing.
Patent CN110305010A details a green Grignard route for 2 5-dimethylphenylacetic acid. This method eliminates toxic cyanide and noble metals, ensuring cost reduction and supply reliability.
Patent CN118026867B details a high-efficiency chiral resolution for Mirogabalin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel patent CN116925146A reveals efficient synthesis for battery additives and peptide coupling. Reduces cost and simplifies supply chain for global buyers.
Novel patent CN103880770B enables high-purity chiral morpholine intermediates with reduced costs and scalable supply chain solutions for global pharmaceutical partners.
Novel two-step synthesis for Repaglinide intermediate offering high purity, recyclable solvents, and significant cost reduction in API manufacturing.
Patent CN108929217B reveals a novel Grignard route for high-purity intermediates. This method ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN101346352B reveals efficient Rh-catalyzed asymmetric reduction for Mitiglinide. Offers high optical purity and industrial scalability for diabetes drug intermediates.